CMS Issues National Coverage Determination for Ultrasound Renal Denervation (uRDN) for the Treatment of Hypertension The Centers for Medicare and Medicaid Services (CMS) has issued its National ...

The Paradise uRDN system is currently commercially available for patients in the U.S., having received FDA approval in November 2023. The Paradise Ultrasound Renal Denervation system (Paradise system) ...

Portal vein thrombosis (PVT) is a critical complication in liver cirrhosis (LC), significantly worsening portal hypertension and accelerating the progression to decompensation. Early identification of ...

Portal vein thrombosis (PVT) is a critical complication in liver cirrhosis (LC), significantly worsening portal hypertension and accelerating the progression to decompensation. Early identification of ...

Actively identifying the risk factors and predictive indicators associated with portal vein thrombosis (PVT) in liver cirrhosis (LC) can enable early diagnosis and treatment, which is of great ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Inpatient burden of chimeric antigen receptor T-cell therapy: A National Inpatient Sample study. Time Point Incidence Rate per 100 PY (Warfarin, 95% CI) Incidence Rate per 100 PY (DOAC, 95% CI) Hazard ...

Portal Hypertension Symptoms and Their ComplicationsPortal hypertension is a condition in which increased pressure within the portal vein—an important vessel that carries blood from the stomach and ...

A transjugular intrahepatic portosystemic shunt (TIPS for short) is a procedure meant to help blood flow more easily through your liver. It’s usually done to treat complications caused by liver damage ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...